Phase 1b study of marizomib (MRZ) in combination with temozolomide (Temodar) and radiation in newly diagnosed, Grade 4 malignant glioma
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2017
At a glance
- Drugs Marizomib (Primary) ; Temozolomide
- Indications Glioma
- Focus Adverse reactions
- 24 Jul 2017 According to Novocure media release,Dr. Roger Stupp is the Principal Investigator of this trial.
- 24 Jul 2017 The protocol for addtion of new arm for this study to evaluate the safety of marizomib and temozolomide in combination with Optune has been submitted to an institutional review board, and this arm of the trial is expected to open in the third quarter of 2017.
- 06 May 2016 New trial record